Morphine IV vs Paracetamol IV in Neonates and Infants After Cardiac Surgery

• Status: Completed
• Trial end date: 2020-07-20
• Target enrollment: 0
• Participant gender: All

Summary

The goal of this clinical trial is to compare pain management in neonates and infants under 3 years of age undergoing cardiac surgery with use of cardiopulmonary bypass. Patients will be randomized to either continuous morphine IV (standard) of intermittent paracetamol IV (intervention).

The investigators' hypothesis is that intermittent IV paracetamol is effective as the primary analgesic drug in post-cardiac surgery patients up to 3 years of age and that the use of IV paracetamol will reduce overall morphine requirements.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Erasmus Medical Center
• Collaborators: KU Leuven; UMC Utrecht; University Medical Center Groningen
• Treatments: Acetaminophen; Morphine

Criteria

Inclusion Criteria:

• Informed consent

• Neonates/infants who are 0-36 months old

• Cardiac surgery with the use of CPB.

Exclusion Criteria:

• No informed consent

• Known allergy to or intolerance of paracetamol or morphine

• Administration of opioids in the 24 h prior to surgery

• Hepatic dysfunction defined as three times the reference value of alanine aminotransferase/aspartate aminotransferase (ALAT/ASAT)

• Renal insufficiency at least RIFLE category Risk prior to surgery.